メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
岡山大学 ホーム
English
日本語
岡山大学でコンテンツを検索
ホーム
プロファイル
研究部門
研究成果
設備
活動
プレス/メディア
受賞
Scopus著者プロファイル
江尻 健太郎
Assistant Professor
,
岡山大学病院
h-index
1455
被引用数
18
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2010
2026
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(80)
類似のプロファイル
(6)
フィンガープリント
Kentaro Ejiriが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Pulmonary Hypertension
100%
Coronary Artery Disease
35%
Cardiovascular System
33%
Acute Heart Infarction
32%
Angioplasty
32%
Chronic Thromboembolic Pulmonary Hypertension
32%
Combination Therapy
27%
Lung Transplantation
26%
Lung Artery Pressure
25%
Catheterization
23%
Computed Tomography Angiography
22%
Blood Vessel Injury
21%
Pulmonary Artery Aneurysm
21%
Transdermal Patch
21%
Nonalcoholic Fatty Liver
21%
Atrial Septal Defect
21%
Hemodynamic
19%
Coronary Computed Tomography Angiography
18%
Hazard Ratio
18%
Computer Assisted Tomography
18%
Induced Hypothermia
18%
Congestive Heart Failure
17%
Coronary Artery
17%
Proportional Hazards Model
16%
Cohort Analysis
15%
Lung Vascular Resistance
15%
Heart Arrest
14%
Out of Hospital Cardiac Arrest
13%
Diagnosis
13%
Atrial Fibrillation
13%
Long Term Survival
13%
Diabetes Mellitus
12%
Atherosclerosis
12%
Blood Vessel Calcification
12%
Isotopes of Calcium
12%
Patient with Diabetes
12%
Metabolic Syndrome
12%
Apoplexy
12%
Diagnostic Performance
12%
Arteriosclerosis Obliterans
12%
Major Adverse Cardiac Event
11%
Rapamycin
10%
Extracorporeal Life Support
10%
Lipoprotein
10%
Right Bundle Branch Block
10%
Hypothermia
10%
Hereditary Hemorrhagic Telangiectasia
10%
Diabetes
10%
Pulse Wave Velocity
10%
Remote Sensing
10%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
56%
Pulmonary Hypertension
51%
Randomized Controlled Trial
50%
Heart Muscle Injury
43%
Luseogliflozin
43%
Chronic Thromboembolic Pulmonary Hypertension
32%
Heart Failure with Preserved Ejection Fraction
32%
Nicorandil
29%
Congestive Heart Failure
25%
Voglibose
23%
Diabetes Mellitus
23%
Non Insulin Dependent Diabetes Mellitus
22%
Blood Vessel Injury
21%
Nonalcoholic Fatty Liver
21%
Cardiovascular Disease
21%
Sodium Glucose Cotransporter 2 Inhibitor
18%
Heart Failure
15%
Stable Angina Pectoris
15%
Brain Natriuretic Peptide
14%
Inflammation
13%
Heart Infarction
13%
Biological Marker
12%
Peripheral Occlusive Artery Disease
12%
Acute Coronary Syndrome
12%
Major Adverse Cardiac Event
11%
Combination Therapy
10%
Prostacyclin
10%
Acute Kidney Failure
10%
Pulmonary Artery Aneurysm
10%
Ischemia
10%
Creatinine
10%
Lipoprotein A
10%
Fatty Liver
10%
Acute Heart Failure
10%
Aptamer
10%
New-Onset Atrial Fibrillation
10%
Riociguat
10%
Acute Heart Infarction
10%
Transdermal Patch
10%
Nanoparticle
10%
Heart Atrium Septum Defect
10%
Drug Delivery System
10%
Prospective Cohort Study
10%
Advanced Glycation End Product Receptor
10%
Edoxaban
10%
Anticoagulant Agent
10%
Malignant Neoplasm
10%
Venous Thromboembolism
10%
Thorax Pain
10%
Coronary Artery Calcification
10%
Keyphrases
Pulmonary Arterial Hypertension
32%
Elective Percutaneous Coronary Intervention
24%
Patients with Diabetes Mellitus
21%
Remote Ischemic Preconditioning
21%
Protective Effect
21%
Bisoprolol Transdermal Patch
21%
Luseogliflozin
21%
Pericoronary Fat Attenuation Index
21%
Heart Failure with Preserved Ejection Fraction (HFpEF)
21%
Heart Failure
16%
Lung Transplantation
15%
Randomized Controlled Trial
13%
Catheterization
13%
Long-term Survival
13%
Japan
12%
Heart Failure Hospitalization
12%
Epoprostenol
12%
Atherosclerotic Risk Factors
12%
Cardiovascular Events
11%
Coronary Computed Tomography Angiography
11%
Pathophysiology
10%
Preventive Effect
10%
Nanoparticle-mediated Drug Delivery
10%
Propensity Score Matching Study
10%
Repair Strategy
10%
Single Center
10%
Pulmonary Vascular Resistance
10%
Pulmonary Aneurysm
10%
Postoperative Atrial Fibrillation
10%
Clinical High Risk
10%
Pulmonary Artery Dilatation
10%
Pulmonary Artery Aneurysm
10%
Acute Kidney Injury
10%
Patient Survival
10%
Diabetic Cardiomyopathy
10%
3-year Follow-up
10%
Cardiac Computed Tomography
10%
Transesophageal Echocardiography
10%
Patent Foramen Ovale
10%
Heritable Pulmonary Arterial Hypertension
10%
Cigarette Smoking
10%
Long-stay Patients
10%
Pulse Wave Velocity
10%
Multi-center Randomized Study
10%
Sirolimus-eluting Stent
10%
Bare Metal Stent
10%
Interventional Trial
10%
Defect Study
10%
Peri-procedural
10%
Lung Perfused Blood Volume
10%
